Severe cytokine release syndrome in a patient receiving PD-1-directed therapy
Author:
Affiliation:
1. Cancer and Blood Diseases Institute; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio
2. Department of Pathology; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio
Publisher
Wiley
Subject
Oncology,Hematology,Pediatrics, Perinatology and Child Health
Reference18 articles.
1. Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy;Teachey;Blood,2013
2. Current concepts in the diagnosis and management of cytokine release syndrome;Lee;Blood,2014
3. Nivolumab plus ipilimumab in advanced melanoma;Wolchok;N Engl J Med,2013
4. Toxicities of immunotherapy for the practitioner;Weber;J Clin Oncol,2015
5. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia;Davila;Sci Transl Med,2014
Cited by 136 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Toxicity profiles of immune checkpoint inhibitors in nervous system cancer: a comprehensive disproportionality analysis using FDA adverse event reporting system;Clinical and Experimental Medicine;2024-09-09
2. Cytokine release syndrome following COVID-19 infection during treatment with nivolumab for cancer of esophagogastric junction carcinoma: a case report and review;International Journal of Emergency Medicine;2024-09-02
3. A Novel Monoclonal Antibody against PD-1 for the Treatment of Viral Oncogene-Induced Tumors or Other Cancer;Cancers;2024-09-01
4. Misdiagnosis of severe and atypical oxaliplatin‑related hypersensitivity reaction following chemotherapy combined with PD‑1 inhibitor: A case report and literature review;Oncology Letters;2024-07-23
5. Tocilizumab and CytoSorb for delayed severe cytokine release syndrome after ipilimumab plus nivolumab immunotherapy;Immunotherapy;2024-07-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3